Development of the ATAQ-IPF: a tool to assess quality of life in IPF - Wikidata - awgldk - TriplyDB

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

http://www.wikidata.org/entity/Q34060716

about

Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis IPF clinical trial design and endpoints A mixed-methods study of the Care Needs of individuals with idiopathic Pulmonary fibrosis and their carers--CaNoPy: a study protocol.Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)The need for patient-centred clinical research in idiopathic pulmonary fibrosis Patient-reported outcomes in idiopathic pulmonary fibrosis research Content validity of CASA-Q cough domains and UCSD-SOBQ for use in patients with Idiopathic Pulmonary Fibrosis Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Clinical trials and tribulations--lessons from pulmonary fibrosis.Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?Symptom-based management of the idiopathic interstitial pneumonia.Optimizing quality of life in patients with idiopathic pulmonary fibrosis.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease.Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.Patient-reported outcome measures in idiopathic pulmonary fibrosis: Where do we stand?The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.Psychometric properties of the St George's Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials.Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives

P2860

Q26747694-57AFF2AA-1232-43ED-8607-AD7E9CF0A0D3 Q26995648-B5F1636D-2D41-4711-8CFA-02F1FBCBD7F2 Q30542598-8A952DBF-FAE9-4CBA-B2A8-80FD6D410640 Q34419914-3C0F4449-F636-4405-9225-B5D08F5D9553 Q35785546-A1333AE8-08C8-411D-9B53-8940658BC0BB Q36182189-C9F936C2-420B-4AC9-891F-EAE2DCD8B1BC Q36647810-C3E34BD2-89CA-4607-9865-6AAA7A15DF62 Q36726418-98ACDF02-B408-4EB3-9E1F-9D4EE218B8AE Q36896973-BD959910-7249-4EED-8FF4-B80E42898F09 Q38064381-DD6A4624-6C6D-4DB8-B0BC-E333FFA8BCBC Q38233856-2B9C31E3-47CE-4E83-A567-045A5ED22316 Q38602725-CB7ED476-B4EB-4322-9A3E-88A8E7CA9035 Q39108878-70571E7F-48F4-4C46-B597-12FFC5EA1AFA Q39330304-3FC42340-0A69-4E10-8A02-96463EF13E35 Q41642420-33F7EA26-58D6-40B6-A7C7-72976313E046 Q47101057-E8EFD1CA-B257-4F1A-8DE7-B062A297BA36 Q47942905-1A564AFE-218D-4B12-A722-ED66318301ED Q51410723-F244BC4B-73CA-4D99-969B-6EDA4F74229D Q51763710-6C0FDEEF-6D79-41D1-8AD1-60A98F9CE738 Q55021513-E8D0405E-9BAD-4449-AD8F-F6523F5CF23E Q57071456-40C6F1DE-06DE-425B-8903-C7E9CBE02C39

P2860

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

http://www.wikidata.org/entity/Q34060716

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@ast

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@en

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@nl

type

label

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@ast

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@en

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@nl

prefLabel

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@ast

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@en

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@nl

P1433

Q34060716-0C266712-5CB9-4684-AAC8-97CFE371040D

P1476

Q34060716-6CDAB46D-81A1-4BBC-8A53-4D2E32EA08E9

P2093

Q34060716-37FB6225-DADB-4B57-8E1E-0162370A5A4A

Q34060716-4407A4FF-235B-485E-9F19-77F98EA58171

Q34060716-85CEFF44-48ED-4AF5-ABA4-85B94D2CBDA5

Q34060716-8CB69B57-2DF5-4C7A-89C9-17514AD9850C

Q34060716-8E3F0733-6F1E-4F26-AD06-94292BDB35E4

Q34060716-BAF04684-E239-4A1E-8B3F-6272605E6B60

P2860

Q34060716-0DCCAFB2-656F-4404-922C-69D5F2939670

Q34060716-332871DE-690C-42BE-9B0B-D275BDE7D307

Q34060716-3398DE7B-231F-45D8-BD88-DF458BC763A6

Q34060716-6EE23774-EA99-468E-AACB-6BA088AEB69A

Q34060716-714A4F4A-E932-4C9C-8D9E-DDDB4ED78FA7

Q34060716-76E92DAF-872C-4569-B808-70390244A887

Q34060716-B33B9459-FDF5-4A18-89C3-165D4CB11A45

Q34060716-B4ADCCAC-BF17-4FD7-9AA2-6B7EC2B2F7A2

Q34060716-E28E401A-6BB0-4A69-8C15-7F18DFCED500

Q34060716-E4ED866A-3366-4FDF-A777-E8D7A6A01041

P2888

Q34060716-7C42938E-B54F-47C0-BCC6-227D358C1674

P304

Q34060716-F78C91CE-ED49-4A59-AC95-FD5E8ED6AA8C

P31

Q34060716-1C13DB25-D410-4C49-A3E4-95CDDD8631FA

P356

Q34060716-A6B64361-1705-4546-9A04-64BD99D92D13

P478

Q34060716-67A07FA5-F5FD-4EF1-B166-A204AAB476C2

P577

Q34060716-158DEE73-F20E-4D06-A935-0CBAE06E1A5D

P5875

Q34060716-62230703-2A6F-4803-9C05-3F21355EE408

P6179

Q34060716-BFF7D36B-B712-4397-AB2D-50218E29E323

P698

Q34060716-08A6F61F-CAB7-4B81-9FAB-824AC738314F

P921

Q34060716-AC3A6A31-ED18-49DF-8F5B-627BB41F38B0

P932

Q34060716-7B7BE405-FAA3-4D72-AFE0-5ED7D40350C6

P356

P1433

Health and Quality of Life Outcomes

P1476

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

@en

P2093

David B Sprunger

http://www.w3.org/2001/XMLSchema#string

Frederick S Wamboldt

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Swigris

http://www.w3.org/2001/XMLSchema#string

Kathy E Green

http://www.w3.org/2001/XMLSchema#string

Kevin K Brown

http://www.w3.org/2001/XMLSchema#string

Sandra R Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.

Standardization of Spirometry, 1994 Update. American Thoracic Society

Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Health-related quality of life among patients with idiopathic pulmonary fibrosis.

Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis.

Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

Development and first validation of the COPD Assessment Test.

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire.

Measuring change over time: assessing the usefulness of evaluative instruments.

A scale for assessing quality of life in adult asthma sufferers.

P2888

P304

77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7525-8-77

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45438269

http://www.w3.org/2001/XMLSchema#string

P6179

1023694296

http://www.w3.org/2001/XMLSchema#string

P698

20673370

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

2920246

http://www.w3.org/2001/XMLSchema#string